Drug Trial Radar · NCT05256732
Study of AT-527 in Healthy Subjects Under Fasting Conditions or With a Meal
Last checked: Nov 20, 2026Latest source record: Oct 18, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
136
Actual
Start
Feb 22, 2022
Primary completion
Aug 23, 2022
Study completion Aug 23, 2022
Sponsor
- Lead sponsor
- Atea Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 25, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will assess the safety, tolerability and pharmacokinetics (PK) of AT-527 following oral administration under fasting conditions or with a meal in healthy adult subjects
Conditions
- Healthy Volunteer Study
Interventions
AT-527 fastedDrug
AT-527 administered twice daily (BID) for 5 days fasted
Placebo Comparator fastedOther
Matching placebo administered twice daily (BID) for 5 days fasted
AT-527 fedDrug
AT-527 administered twice daily (BID) for 5 days fed
Placebo Comparator fedOther
Matching placebo administered twice daily (BID) for 5 days fed
AT-527Drug
AT-527 administered twice daily (BID)
AT-527 single doseDrug
AT-527 single dose fasted/fed cross-over
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics (PK) of AT-527Time frame: Day 1
- Pharmacokinetics (PK) of AT-527Time frame: Day 1
- Pharmacokinetics (PK) of AT-527Time frame: Day 1
- Proportions of subjects experiencing treatment-emergent adverse eventsTime frame: Day 1-10
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Atea Study Site
Québec, Montreal, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.